| Funding Agency |
|
| Title |
Phase 3,Multictr,Random,Double-Blind, Parallel-Group,Placebo-Contrlld,Flex Dose Titration, Efficacy and Safety Study of Study Drug In Combo with Antidepressant in Trtmnt of Adults with Major Depressive Disorder With Inadeq Resp to Prosp Trtmnt w Antidepr |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Double-Blind, Placebo-Controlled Evaluation of The Safety and Efficacy of Study Drug in Patients with Bipolar Depression |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy, Safety and Tolerability of Study Drug in The Treatment of Children and Adolescent Oupatients with Major Depressive Disorder |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Multi-Ctr,Random,Double-Blind,Placebo-Contrlld,Parallel Grp Study to Eval the Efficacy and Safety of Low-Dose Study Drug for Adj Therapy in Adult Patients with OCD Who Have Not Adeq Responded to Trtmnt with a Selective Serotonin Reuptake Inhibitor |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
An Open-Label, Multicenter Study Evaluating The Safety and Tolerability of Once-Weekly Oral Study Drug in Children and Adoelscents with Tourette's Disorder |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Phase 3, Randomized,Double-Blind,Parallel-Group,Placebo-Controlled,Fixed-Dose Study Comparing The Efficacy and Safety of 2 Doses of Study Drug in Acute Treatment of Adults With Major Depressive Disorder |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Phase 3, Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Study Drug in Subjects with Major Depressive Disorder |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Twelve-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study with Follow-Up Evaluting the Safety and Efficacy of Study Drug For Smoking Cessation in Healthy Adolescent Smokers |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Phase 3, Open-Label Multicenter, 12-Mo Ext Safety and Tolerability Study of Study Drug in Combination With Antidepressant in Trtmnt of Adults with Maj Depressive Disorder with Residual Symptoms or Inadeq Response Following Trtmnt with Antidepressan |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study To Evaluate Study Drug in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
|
| Title |
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety and Efficacy of Flexible-Dose Once-Weekly Oral Study Drug in Children and Adolescents with Tourette's Disorder |
| Status |
Active |
| Period |
1/2011 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
